BERNADETTE SCHRIML: Open Payments
NPI 1619732112 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,336 in 179 payments from 47 companies in 2025. Trend: 2023 $21 · 2024 $4,564 · 2025 $4,336
Food & beverage: $4,249Education: $87
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $331 |
| Janssen Biotech, Inc. | 13 | $294 |
| Merck Sharp & Dohme LLC | 11 | $284 |
| Karyopharm Therapeutics Inc. | 2 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $229 |
| ABBVIE INC. | 11 | $226 |
| E.R. Squibb & Sons, L.L.C. | 6 | $216 |
| Regeneron Healthcare Solutions, Inc. | 9 | $209 |
| Celgene Corporation | 9 | $169 |
| Genentech USA, Inc. | 8 | $168 |
Products named: XPOVIO, KEYTRUDA, Nubeqa, LIBTAYO, OPDIVO, PLUVICTO, OJJAARA, Enhertu.
Industry payments across IN — which companies pay providers there.
